Table of Contents
ISRN Psychiatry
Volume 2014 (2014), Article ID 652750, 8 pages
http://dx.doi.org/10.1155/2014/652750
Clinical Study

Metabotropic Glutamate Receptor 5 Negative Modulation in Phase I Clinical Trial: Potential Impact of Circadian Rhythm on the Neuropsychiatric Adverse Reactions—Do Hallucinations Matter?

1Rob Giel Research Centre, Department of Psychiatry, University Medical Centre Groningen (UMCG), Hanzeplein 1, 9713 GZ Groningen, The Netherlands
2Department of Epidemiology (Medical Statistics), University Medical Centre Groningen (UMCG), Hanzeplein 1, 9713 GZ Groningen, The Netherlands

Received 30 October 2013; Accepted 21 January 2014; Published 4 March 2014

Academic Editors: C. Bonetto and A. Squassina

Copyright © 2014 Khalid Abou Farha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Khalid Abou Farha, Richard Bruggeman, and Corine Baljé-Volkers, “Metabotropic Glutamate Receptor 5 Negative Modulation in Phase I Clinical Trial: Potential Impact of Circadian Rhythm on the Neuropsychiatric Adverse Reactions—Do Hallucinations Matter?,” ISRN Psychiatry, vol. 2014, Article ID 652750, 8 pages, 2014. doi:10.1155/2014/652750